Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BESSEMER GROUP INC AFK VanEck ETF Trust 13G 8.69% 2y
TIAA-CREF Investment Management, LLC ALT Altimmune, Inc. 13G/A 2.88% 2y
PURA VIDA INVESTMENTS, LLC NSTG NanoString Technologies, Inc. 13G/A 0% 2y
Kopernik Global Investors, LLC NAK Northern Dynasty Minerals Ltd 13G/A 6.62% 2y
Nantahala Capital Management, LLC DHX Dhi Group, Inc. 13G/A 5.6% 2y
Atlas Merchant Capital LLC HCVI Hennessy Capital Investment Corp. VI Class A Common Stock 13G/A 9.5% 2y
Madison Avenue Partners, LP OVID Ovid Therapeutics Inc. 13G/A 5.2% 2y
683 Capital Management, LLC PANA Panacea Acquisition Corp. II Class A Ordinary Shares 13G/A 0% 2y
FIR TREE CAPITAL MANAGEMENT LP APCA AP Acquisition Corp 13G 5.34% 2y
Redmile Group, LLC REPL Replimune Group, Inc. 13G/A 7.4% 2y
RA CAPITAL MANAGEMENT, L.P. UNCY Unicycive Therapeutics, Inc. 13G/A 9.99% 2y
ARMISTICE CAPITAL, LLC YYAI Airwa Inc. 13G/A 4.99% 2y
AQR CAPITAL MANAGEMENT LLC GMFI Aetherium Acquisition Corp. Class A Common Stock 13G 5.65% 2y
BIOTECHNOLOGY VALUE FUND L P EOCN EoCene Ltd. 13G/A 0% 2y
Radcliffe Capital Management, L.P. AENT Alliance Entertainment Holding Corp 13G/A 0% 2y
Deep Track Capital, LP EWTX Edgewise Therapeutics, Inc. 13G/A 4% 2y
CVI Investments, Inc. EBET EBET, INC. Common Stock 13G/A 0.4% 2y
Dan Oren ROIV Roivant Sciences Ltd. 13G/A 12.78% 2y
Oaktree Capital Holdings, LLC FEXD Fintech Ecosystem Development Corp. Class A Common Stock 13G 0% 2y
Fourthstone LLC MRBK Meridian Corp 13G 9.27% 2y
Scooby Aggregator, LP WOOF Petco Health & Wellness Company, Inc. 13G/A 68.4% 2y
TENOR CAPITAL MANAGEMENT Co., L.P. ACAH Atlantic Coastal Acquisition Corp. Class A Common Stock 13G/A 6.6% 2y
RPD Fund Management LLC GRPN Groupon, Inc. 13G/A 0% 2y
Avoro Capital Advisors LLC MRTX Mirati Therapeutics, Inc. Common Stock 13G/A 7% 2y
First Trust Capital Management L.P. HSPOF Horizon Space Acquisition I Corp. 13G 6.56% 2y
JANUS HENDERSON GROUP PLC LNTH Lantheus Holdings, Inc. 13G 5.8% 2y
Bell Edward Allen OVBC Ohio Valley Banc Corp 13G 8.02% 2y
First Light Asset Management, LLC PHLT Performant Healthcare, Inc. Common Stock 13G/A 13.43% 2y
ORBIMED ADVISORS LLC VSTM Verastem, Inc. 13G/A 6.1% 2y
Galileo (PTC) Ltd HOOD Robinhood Markets, Inc. 13G/A 7.4% 2y
Venrock Healthcare Capital Partners III, L.P. RYZB RayzeBio, Inc. Common Stock 13G/A 6.7% 2y
Dragoneer Investment Group, LLC GTM ZoomInfo Technologies Inc. 13G 5.7% 2y
T. Rowe Price Investment Management, Inc. ESAB ESAB Corp 13G/A 14% 2y
Avoro Capital Advisors LLC IOBTQ IO Biotech, Inc. 13G/A 0% 2y
Travis Boersma BROS Dutch Bros Inc. 13G/A 52.13% 2y
RTW INVESTMENTS, LP CCCC C4 Therapeutics, Inc. 13G/A 0% 2y
BAKER BROS. ADVISORS LP TSVT 2seventy bio, Inc. Common Stock 13G/A 4.99% 2y
RBC Global Asset Management Inc. TXR Torex Resources Inc. 13G/A 4.33% 2y
ARMISTICE CAPITAL, LLC MBIO Mustang Bio, Inc. 13G 9.99% 2y
COMPASS GROUP LLC VSTA Vasta Platform Limited Class A Ordinary Shares 13G/A 21.8% 2y
Calamos Market Neutral Income Fund, a series of Calamos Investment Trust HMA Heartland Media Acquisition Corp. 13G 0% 2y
T. Rowe Price Investment Management, Inc. NTST NETSTREIT Corp. 13G 7.2% 2y
PRICE T ROWE ASSOCIATES INC /MD/ REPL Replimune Group, Inc. 13G/A 9.9% 2y
Checkpoint Capital L.P. KALA KALA BIO, Inc. 13G/A 0% 2y
SPROTT INC. GATO Gatos Silver, Inc. 13G 5% 2y
FIR TREE CAPITAL MANAGEMENT LP FZT FAST Acquisition Corp. II 13G/A 0% 2y
Cormorant Asset Management, LP ELDN Eledon Pharmaceuticals, Inc. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. SEE SEALED AIR CORP 13G 7.2% 2y
Avoro Capital Advisors LLC APLS Apellis Pharmaceuticals, Inc. 13G/A 9.9% 2y
RA CAPITAL MANAGEMENT, L.P. ASND Ascendis Pharma A/S 13G/A 17.5% 2y